ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Vanderbilt physician-scientist Philip Browning, 51, dead of colon cancer.

June 25, 2004

Cooperative group chairman suggest changes to incentive system.

August 13, 2004

Board Oks Construction PA Fro Breast Cancer Research Facilities

July 9, 1993

UCLA Forms Environmental Genomics Program

March 14, 2003

Society Support Program for Training Cytotechnologists

November 29, 1991

Adamson Is Named Acting Deputy; Broder Begins Search For Roper Replacement

May 25, 1990